MRI可预测长期口服抗凝患者颅内出血风险
研究纳入937例近期心源性栓塞性卒中且新使用口服抗凝药的患者,基线MRI评估微出血、白质高信号和皮质表面铁沉积。平均随访23.1个月,18例(1.9%)发生颅内出血。多变量分析显示微出血(HR 2.7,95%CI 1.1-7,p=0.034)和中重度白质高信号(HR 5.7,95%CI 1.6-20,p=0.006)与颅内出血相关,C指数0.76(95%CI 0.66-0.85)。
要点
- 微出血与中重度白质高信号均独立增加口服抗凝患者颅内出血风险。
- 两者并存时颅内出血率最高,达3.76/100患者年(95%CI 1.62-7.4)。
- 基线MRI有助于评估心源性卒中患者口服抗凝的出血风险。
核心结论
- 口服抗凝患者若存在晚期脑小血管病(微出血和中重度白质高信号),颅内出血风险增加。
研究设计与样本
- 多中心前瞻性观察研究,纳入937例年龄大于64岁、近期心源性栓塞性卒中且新使用口服抗凝药的患者。
主要发现
- 微出血检出207例(22.5%),中重度白质高信号419例(45.1%),皮质表面铁沉积28例(3%)。
- 平均随访23.1±6.8个月,18例(1.9%)发生颅内出血。
- 多变量分析中微出血HR 2.7(95%CI 1.1-7,p=0.034),中重度白质高信号HR 5.7(95%CI 1.6-20,p=0.006)。
- 模型C指数0.76(95%CI 0.66-0.85)。
- 微出血和中重度白质高信号并存者颅内出血率最高,为3.76/100患者年(95%CI 1.62-7.4)。
临床怎么用
- 对心源性栓塞性卒中拟长期口服抗凝的患者,可考虑基线MRI评估微出血和白质高信号以辅助出血风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We tested the hypothesis that the risk of intracranial hemorrhage (ICH) in patients with cardioembolic ischemic stroke who are treated with oral anticoagulants (OAs) can be predicted by evaluating surrogate markers of hemorrhagic-prone cerebral angiopathies using a baseline MRI. METHODS: Patients were participants in a multicenter and prospective observational study. They were older than 64 years, had a recent cardioembolic ischemic stroke, and were new users of OAs. They underwent a baseline MRI analysis to evaluate microbleeds, white matter hyperintensities, and cortical superficial siderosis. We collected demographic variables, clinical characteristics, risk scores, and therapeutic data. The primary endpoint was ICH that occurred during follow-up. We performed bivariate and multivariate Cox regression analyses. RESULTS: We recruited 937 patients (aged 77.6 ± 6.5 years; 47.9% were men). Microbleeds were detected in 207 patients (22.5%), moderate/severe white matter hyperintensities in 419 (45.1%), and superficial siderosis in 28 patients (3%). After a mean follow-up of 23.1 ± 6.8 months, 18 patients (1.9%) experienced an ICH. In multivariable analysis, microbleeds (hazard ratio 2.7, 95% confidence interval [CI] 1.1-7, p = 0.034) and moderate/severe white matter hyperintensities (hazard ratio 5.7, 95% CI 1.6-20, p = 0.006) were associated with ICH (C index 0.76, 95% CI 0.66-0.85). Rate of ICH was highest in patients with both microbleed and moderate/severe WMH (3.76 per 100 patient-years, 95% CI 1.62-7.4). CONCLUSION: Patients taking OAs who have advanced cerebral small vessel disease, evidenced by microbleeds and moderate to severe white matter hyperintensities, had an increased risk of ICH. Our results should help to determine the risk of prescribing OA for a patient with cardioembolic stroke. CLINICALTRIALSGOV IDENTIFIER: NCT02238470.
引用
- Martí-Fàbregas J, Medrano-Martorell S, Merino E, et al. MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation. Neurology. 2019. PMID: 31004066. doi:10.1212/WNL.0000000000007532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。